Literature DB >> 24569071

The mental health characteristics of pregnant women with depressive symptoms identified by the Edinburgh Postnatal Depression Scale.

Linda B Lydsdottir1, Louise M Howard, Halldora Olafsdottir, Marga Thome, Petur Tyrfingsson, Jon F Sigurdsson.   

Abstract

OBJECTIVE: Few studies are available on the effectiveness of screening tools such as the Edinburgh Postnatal Depression Scale (EPDS) in pregnancy or the extent to which such tools may identify women with mental disorders other than depression. We therefore aimed to investigate the mental health characteristics of pregnant women who screen positive on the EPDS.
METHOD: Consecutive women receiving antenatal care in primary care clinics (from November 2006 to July 2011) were invited to complete the EPDS in week 16 of pregnancy. All women who scored above 11 (screen positive) on the EPDS and randomly selected women who scored below 12 (screen negative) were invited to participate in a psychiatric diagnostic interview.
RESULTS: 2,411 women completed the EPDS. Two hundred thirty-three women (9.7%) were screened positive in week 16, of whom 153 (66%) agreed to a psychiatric diagnostic interview. Forty-eight women (31.4%) were diagnosed with major depressive disorder according to DSM-IV criteria, 20 (13.1%) with bipolar disorder, 93 (60.8%) with anxiety disorders (including 27 [17.6%] with obsessive-compulsive disorder [OCD]), 8 (5.2%) with dysthymia, 18 (11.8%) with somatoform disorder, 3 (2%) with an eating disorder, and 7 (4.6%) with current substance abuse. Women who screened positive were significantly more likely to have psychosocial risk factors, including being unemployed (χ(2)(1) = 23.37, P ≤.001), lower educational status (χ(2)(1)= 31.68, P ≤ .001), and a history of partner violence (χ(2)(1) = 10.30, P ≤ 001), compared with the women who screened negative.
CONCLUSIONS: Use of the EPDS early in the second trimester of pregnancy identifies a substantial number of women with potentially serious mental disorders other than depression, including bipolar disorder, OCD, and eating disorders. A comprehensive clinical assessment is therefore necessary following use of the EPDS during pregnancy to ensure that women who screen positive receive appropriate mental health management. © Copyright 2014 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24569071     DOI: 10.4088/JCP.13m08646

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  22 in total

1.  Looking Beyond the Pain: Can Effective Labor Analgesia Prevent the Development of Postpartum Depression?

Authors:  Paloma Toledo; Emily S Miller; Katherine L Wisner
Journal:  Anesth Analg       Date:  2018-05       Impact factor: 5.108

2.  Consensus Bundle on Maternal Mental Health: Perinatal Depression and Anxiety.

Authors:  Susan Kendig; John P Keats; M Camille Hoffman; Lisa B Kay; Emily S Miller; Tiffany A Moore Simas; Ariela Frieder; Barbara Hackley; Pec Indman; Christena Raines; Kisha Semenuk; Katherine L Wisner; Lauren A Lemieux
Journal:  Obstet Gynecol       Date:  2017-03       Impact factor: 7.661

3.  Screening for PTSD during pregnancy: a missed opportunity.

Authors:  Avelina C Padin; Natalie R Stevens; Mandy L Che; Ihuoma N Erondu; Marisa J Perera; Madeleine U Shalowitz
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-14       Impact factor: 3.105

4.  Cortisol response to the Trier Social Stress Test in pregnant women at risk for postpartum depression.

Authors:  Kristina M Deligiannidis; Aimee R Kroll-Desrosiers; Abby Svenson; Nina Jaitly; Bruce A Barton; Janet E Hall; Anthony J Rothschild
Journal:  Arch Womens Ment Health       Date:  2016-03-07       Impact factor: 3.633

Review 5.  [Mental disorders in pregnancy and postpartum : Prevalence, course, and clinical diagnostics].

Authors:  C Kühner
Journal:  Nervenarzt       Date:  2016-09       Impact factor: 1.214

6.  Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression.

Authors:  Kristina M Deligiannidis; Aimee R Kroll-Desrosiers; Shunyan Mo; Hien P Nguyen; Abby Svenson; Nina Jaitly; Janet E Hall; Bruce A Barton; Anthony J Rothschild; Scott A Shaffer
Journal:  Psychoneuroendocrinology       Date:  2016-05-09       Impact factor: 4.905

7.  White matter integrity in medication-free women with peripartum depression: a tract-based spatial statistics study.

Authors:  Michelle Silver; Constance M Moore; Vanessa Villamarin; Nina Jaitly; Janet E Hall; Anthony J Rothschild; Kristina M Deligiannidis
Journal:  Neuropsychopharmacology       Date:  2018-02-05       Impact factor: 7.853

8.  Perceptions, Uses of, and Interests in Complementary Health Care Approaches in Depressed Pregnant Women: The PAW Survey.

Authors:  Jennifer Matthews; Jennifer L Huberty; Jenn A Leiferman; Darya McClain; Linda K Larkey
Journal:  J Evid Based Complementary Altern Med       Date:  2016-04-12

9.  A transdiagnostic approach to conceptualizing depression across the perinatal period in a high-risk sample.

Authors:  Amy L Cochran; Blaire C Pingeton; Sherryl H Goodman; Heidemarie Laurent; Paul J Rathouz; D Jeffrey Newport; Zachary N Stowe
Journal:  J Abnorm Psychol       Date:  2020-08-27

10.  Peripartum depression: Does risk versus diagnostic status impact mother-infant bonding and perceived social support?

Authors:  Megan M Hare; Aimee Kroll-Desrosiers; Kristina M Deligiannidis
Journal:  Depress Anxiety       Date:  2020-12-07       Impact factor: 6.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.